tldrdailynews.com logo

FDA Publishes Rejection Letters to Increase Transparency in Drug Approval Process

1 min read
Source: STAT
FDA Publishes Rejection Letters to Increase Transparency in Drug Approval Process
Photo: STAT
TL;DR

The FDA released over 200 letters sent to drug companies regarding rejected medicines, focusing on transparency by compiling these communications, including 14 published for the first time, covering decisions from 2020 to 2024, with some redactions for privacy.

Topics:businesshealth#drug-approval-process#drug-rejection-letters#fda#health#pharmaceutical-industry#transparency
Share this article
  1. FDA publishes rejection letters sent to drugmakers, with a big caveat  STAT
  2. F.D.A. Posts Collection of Letters Outlining Concerns About New Drugs  The New York Times
  3. Makary targets pharma industry 'spin' as FDA opens rejection letter vault  FirstWord Pharma
  4. FDA, in policy shift, publishes some drug rejection letters  BioPharma Dive
  5. FDA releases ‘initial batch’ of more than 200 drug rejection letters  Fierce Biotech

Want the full story? Read the original reporting

Read on STAT